Susceptibility genes for coronary heart disease and myocardial infarction

Acute Cardiac Care

Volumn 13, Issue 3, 2011, Pages 136-142

  Kibos, Ambrose ^a   Guerchicoff, Alejandra ^b  

^a Bathurst Regional Hospital Centre   (Canada)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Coronary artery disease; Genetics; myocardial infarction; Genome wide association studies; Sudden death; single nucleotide polymorphism

Indexed keywords

LYMPHOTOXIN;

CHROMOSOME; DIABETES MELLITUS; DYSLIPIDEMIA; GENE SEQUENCE; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOME; HAPLOTYPE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROTEOMICS; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE;

CORONARY DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 80052469124     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.3109/17482941.2011.606477     Document Type: Review

References (46)

1. International H 1. uman Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004;431:931-45.
2. L opez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006;367:1747-57.
3. C olditz GA, Stampfer MJ, Willett W, Rosner B, Spizer FE, Hennkens CH. A prospective study of parental history of myocardial infarction and coronary heart disease in women. Am J Epidemiol 1986;123:48-58.
4. L ewis D, Wang Q, Topol EJ. Ischemic heart disease. Nature Encyclopedia of Life Sciences 2002;10:508-15.
5. S hen G, Archacki SR, Wang Q. Th e molecular genetics of coronary artery and myocardial infarction. Acute Coronary Syndromes 2004;6:129-41.
6. S childkraut JM, Myers RH, Cupples LA, Dan K, Kiel MA, William BK. Coronary risk associated with age and sex of parental heart disease in Framingham Study. Am J Cardiol. 1989;64:555-9.
7. Z ipes DP, Wellens HJ. Sudden Cardiac death. Circulation 1998;98:2334-51.
8. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990 - 2020: Global burden of disease study. Lancet 1997;1498-504.
9. Q ing W. Molecular genetics of coronary artery disease. Curr Opin Cardiol. 2005;20:182-8.
10. K ullo IJ, Ding K. Mechanisms of disease: the genetic basis of coronary heart disease. Nat Clin Pract Cardiovasc Med;4:558-69.
11. T opol EJ, Smith J, Plow EF, Wang QK. Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet;15:R117- 23.
12. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM., et al. General cardiovascular risk profi le for use in primary care: Th e Framingham Heart Study. Circulation 2008;117:743-53. Epub 2008 Jan 22.
13. G ail MH. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst. 2008;100:1037-41.
14. J anssens AC, van Duijn CM. Genome-based prediction of common diseases: Advances and prospects. Hum Mol Genet. 2008;17:166-73.
15. M osca L. C-reactive protein- t o screen or not to screen? N Engl J Med. 2002;20:1615-7.
16. M anolio T. Novel risk markers and clinical practice. N Engl J Med. 2003;17:1587-9.
17. Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK., et al. American Heart Association Council on Epidemiology and Prevention; American Heart Association Stroke Council; Functional Genomics and Translational Working Group. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: A scientifi c statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation;115:2878-901.
18. B roeckel U, Hengstenberg C, Mayer B, Holmer S, Martin LJ, Comuzzie AG., et al. comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet. 30:210-4.
19. H elgadottir A, Manolescu A, Helgason A, Th orleifsson G, Th orsteinsdottir U. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity specifi c risk of myocardial infarction. Nat Genet 2006;38:68-74.
20. M cPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007;316:1488-91.
21. H elgadottir A, Th orleifsson G, Manolescu A, Gretarsdottir S, Blondal T. A common variant on chromosome 9p21 aff ects the risk of myocardial infarction. Science;316:1491-3.
22. W ellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature ;447:661-78.
23. S amani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B., et al. WTCCC and the Cardiogenics Consortium. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:443-53.
24. S cott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL., et al. A genomewide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007;316:1341-5.
25. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H., et al. Genome-wide association analysis identifi es loci for type 2 diabetes and triglyceride levels. Science 2007;316:1331-6.
26. Schunkert H, Gótz A, Braund P, McGinnis R, Tregouet DA, Mangino M., et al., Cardiogenics Consortium. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 2008;117:1675-84.
27. B roadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, Green F., et al., PROCARDIS Consortium. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 2008;17:806-14.
28. Jarinova O, Stewart AF, Roberts R, Wells G, Lau P, Naing T., et al. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Th romb Vasc Biol. 2009;29:1671-7.
29. H oldt LM, Beutner F, Scholz M, Gielen S, Gäbel G, Bergert H., et al. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler Th romb Vasc Biol. 2010;30:620-7.
30. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T., et al. Functional SNPs in the lymphotoxin- á gene that are associated with susceptibility to myocardial infarction. Nat Genet. 2002;32:650-4.
31. O zaki K, Inoue K, Sato H, Iida A, Ohnishi Y, Sekine A., et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin- á secretion in vitro. Nature 2004;429:72-5.
32. Ozaki K, Sato H, Iida A, Mizuno H, Nakamura T, Miyamoto Y., et al. A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population. Nat Genet. 2006;38:921-5.
33. O zaki K, Sato H, Inoue K, Tsunoda T, Sakata Y, Mizuno H., et al. SNPs in BRAP associated with risk of myocardial infarction in Asian populations. Nat Genet. 2009;41:329-933.
34. C larke R, Xu P, Bennett D, Lewington S, Zondervan K, Parish S., et al., International Study of Infarct Survival (ISIS) Collaborators. Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study. PLoS Genet. 2006;2:e107.
35. W iller CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R., et al. Newly identifi ed loci that infl uence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008;40:161-9.
36. M yocardial Infarction Genetics Consortium. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009;4:334-41.
37. Trégouët DA, Kónig IR, Erdmann J, Munteanu A, Braund PS, Hall AS., et al., Wellcome Trust Case Control Consortium; Cardiogenics Consortium. Genome-wide haplotype association study identifi es the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet. 2009;41:283-5.
38. Gudbjartsson DF, Bjornsdottir US, 38. Halapi E, Helgadottir A, Sulem P, Jonsdottir GM., et al. Sequence variants aff ecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet. 2009;41:342-7.
39. H inohara K, Nakajima T, Yasunami M, Houda S, Sasaoka T, Yamamoto K., et al. Megakaryoblastic leukemia factor-1 gene in the susceptibility to coronary artery disease. Hum Genet. 2009;126:539-47.
40. R ipatti S, Tikkanen E, Orho-Melander M. A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet 2010;376:1393-400.
41. S andhu M, Wood A, Young E. Genomic risk prediction. Lancet 2010;376:1366-7.
42. R eilly MP, Li M, He J, Ferguson JF, Stylianou IM, Mehta NN., et al. Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium.. Identifi cation of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: Two genome-wide association studies. Lancet 2011;10:61996-4.
43. L otta LA, Peyvandi F. Addressing the complexity of cardiovascular disease by design. Lancet 2011;377:356-8.
44. Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C., et al. Meta-analysis of genome-wide association studies in 80,000 subjects identifi es multiple loci for C-reactive protein. Circulation 2011;123:731-8.
45. Erdmann J, Grosshennig A, Braund PS, Kónig IR, Hengstenberg C, Hall AS.,et al., Italian Atherosclerosis, Th rombosis, and Vascular Biology Working Group; Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium; Cardiogenics Consortium. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet. 2009;41:280-2.
46. H arismendy O, Notani D, Song X, Rahim NG, Tanasa B, Heintzman N., et al. 9P21 DNA variants associated with coronary artery impair interferon-Y signaling response. Nature Rev Genet. 2011;3:264-8.